Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

125.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 295.00
  • 52 Week Low: 70.00
  • Currency: UK Pounds
  • Shares Issued: 68.07m
  • Volume: 163,474
  • Market Cap: 85.09m
  • RiskGrade: 594

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart (06-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 19.6  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 n/a (1.72) (2.50)p n/a n/a n/a n/a 0.0%
30-Jun-19 n/a (1.68) (2.50)p n/a n/a n/a n/a 0.0%
30-Jun-20 0.05 (1.12) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a (2.58) (3.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-23 n/a (3.29) (4.15)p n/a n/a n/a n/a 0.0%
30-Jun-24 n/a (3.20) (3.80)p n/a n/a n/a n/a 0.0%
30-Jun-25 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Sareum Holdings Company Announcements

Director/PDMR Shareholding 29-Dec-2022 15:14 RNS
Results of AGM 16-Dec-2022 15:29 RNS
AGM Statement 16-Dec-2022 07:00 RNS

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 125.00p
Change Today 10.00p
% Change 8.70 %
52 Week High 295.00
52 Week Low 70.00
Volume 163,474
Shares Issued 68.07m
Market Cap 85.09m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average
13.79% below the sector average13.79% below the sector average13.79% below the sector average13.79% below the sector average13.79% below the sector average
Price Trend
24.21% below the market average24.21% below the market average24.21% below the market average24.21% below the market average24.21% below the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sareum Holdings Dividends

No dividends found

Trades for 06-Feb-2023

Time Volume / Share Price
17:08 10,000 @ 125.00p
16:29 5,000 @ 124.00p
16:29 26 @ 126.50p
16:12 859 @ 126.90p
16:09 4,896 @ 122.00p

Sareum Holdings Key Personnel

CEO Timothy J Mitchell

Top of Page